ABCG2 and acute myeloid leukemia: Marzac et al., analyzed the expression and the prognostic value of 22 ABC transporters in a cohort of 281 adult patients with AML, concluding that only ACBB1, ABCC1, and ABCG2 correlated with chemoresistance and had a negative impact on outcome [96].